CALR and neoplasm: As such, unlike silent cell death, NDV triggers ICD, marked by calreticulin (CRT) exposure and DAMP release (e.g., HMGB1, ATP), effectively turning dying tumor cells into an “anticancer vaccine” and creating a bridge between oncolysis and immune activation [56, 57].